Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 20

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 20
---
 Board believes that gender and minority representation is a key component in attaining the diverse array of viewpoints
sought by the Board among its members. The Company also does not have formal stock ownership guidelines for directors, but ownership of
the Company’s Common Stock by directors is encouraged and, in part, facilitated by grants of stock options and restricted stock
awards to directors as described below under “Executive and Director Compensation – Director Compensation.”

Directors are not restricted to term limits, but the
Board considers each director’s tenure, level of involvement on the Board, and other attributes and qualities to determine whether
to approve a director as a nominee for re-election.

The Nominating and Corporate Governance Committee
will consider director candidates recommended by stockholders if provided with the following: (i) the written consent of the candidate(s)
for nomination as a director and verification as to the accuracy of the biographical and other information submitted in support of the
candidate; (ii) a resume or other written statement of the qualifications of the candidate(s) for nomination as a director; and (iii)
all information regarding the candidate(s) and the submitting stockholder that would be required to be disclosed in a proxy statement
filed with the SEC if the candidate(s) were nominated for election to the Board. Any recommendations received from stockholders will be
evaluated in the same manner that other potential nominees are evaluated. Any stockholder that wishes to present a director candidate
for consideration should submit the information identified above pursuant to the procedures set forth above under “Communications
with the Board of Directors.” With respect to the timing of stockholder nominations for the 2026 annual meeting of stockholders
(the “2026 Annual Meeting”), please see the discussion set forth below under “Stockholder Proposals For
2026 Annual Meeting.” The Company received no nominations of board candidates from any stockholders for this year’s Annual
Meeting.

Director Nominee Information

Certain information concerning each director nominee
as of April 8, 2025, is set forth below.

| Director Nominee |     | Age |    |     | Director Since |     | Current Company Position(s)     |
| Maria Zannes, JD |     |     | 69 |     | March 2014     |     | President, CEO, and Director    |
| Steven Girgenti  |     |     | 79 |     | March 2014     |     | Executive Chairman and Director |
| Robert Anderson  |     |     | 84